TQB2928 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TQB2928 Injection, covering 2025-12-12 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors [Phase 1]